It’s important that you know when to delegate shit to other people, in business and investing. If you’re a shitty investor and can’t get to an emotional equilibrium to allow yourself some success, hire someone else to do it. Or, and this is definitely some self-promotion, join services like Exodus, 12631 or After Hours with Option Addict to help get you there.
For me, investing in biotech is hard, because I don’t understand the industry as well as I’d like to. I delegate my biotech research to qualified experts, persons who are able to make better decisions in this field than me. For those of you without the benefit of a high powered rolodex, you can jimmy rig the system by doing some research into what hedge funds crush it in biotech. In my opinion, no one does it better than Baker Brothers.
Coming off their PCYC sale, they just executed a sale of one of their biggest positions this morning, one that will net them well over $1 billion in profits–selling GEVA to ALXN for $230 per share. WOW!
In Exodus, we have some pretty cool institutional tools available and I am going to post the Baker Brothers screen in the Exodus blog today. It’s important to note that GEVA is going out for over $7billion and had zero revenues. This is just an amazing deal that should really light a fire under a wide swath of interesting and innovative biotech names.
I’m gonna talk my book here. I like AGIO, ICPT, JAZZ and ANAC here.
If you enjoy the content at iBankCoin, please follow us on Twitter
ADHD?
Oil is going to do the market a great deal of damage if it holds up here. The rise could show up in the inflation indices the Fed uses and will make people fret about interest rates.
if the Fed threatens to raise rates as a result of the energy complex, the markets will head down 20% i reckon.
Problem with Biotech is that without deep pockets one can quickly become the crushed rather than the crusher.
Building a stock position in ONCE in low 50’s
LJPC for the next Baker Bros win